2020
I. W. Weidling, Wilkins, H. M., Koppel, S. J., Hutfles, L., Wang, X., Kalani, A., Menta, B. W., Ryan, B., Perez-Ortiz, J., T Gamblin, C., and Swerdlow, R. H.,
“Mitochondrial DNA Manipulations Affect Tau Oligomerization.”,
J Alzheimers Dis, vol. 77, no. 1, pp. 149-163, 2020.
E. R. Rosin, Blasco, D., Pilozzi, A. R., Yang, L. H., and Huang, X.,
“A Narrative Review of Alzheimer's Disease Stigma.”,
J Alzheimers Dis, vol. 78, no. 2, pp. 515-528, 2020.
K. Abe, Shang, J., Shi, X., Yamashita, T., Hishikawa, N., Takemoto, M., Morihara, R., Nakano, Y., Ohta, Y., Deguchi, K., Ikeda, M., Ikeda, Y., Okamoto, K., Shoji, M., Takatama, M., Kojo, M., Kuroda, T., Ono, K., Kimura, N., Matsubara, E., Osakada, Y., Wakutani, Y., Takao, Y., Higashi, Y., Asada, K., Senga, T., Lee, L. - J., and Tanaka, K.,
“A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.”,
J Alzheimers Dis, vol. 73, no. 1, pp. 217-227, 2020.
K. Abe, Shang, J., Shi, X., Yamashita, T., Hishikawa, N., Takemoto, M., Morihara, R., Nakano, Y., Ohta, Y., Deguchi, K., Ikeda, M., Ikeda, Y., Okamoto, K., Shoji, M., Takatama, M., Kojo, M., Kuroda, T., Ono, K., Kimura, N., Matsubara, E., Osakada, Y., Wakutani, Y., Takao, Y., Higashi, Y., Asada, K., Senga, T., Lee, L. - J., and Tanaka, K.,
“A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.”,
J Alzheimers Dis, vol. 73, no. 1, pp. 217-227, 2020.
D. P. Devanand, Liu, X., Chunga, R. E., Cohen, H., Andrews, H., Schofield, P. W., Stern, Y., Huey, E. D., Choi, J., and Pelton, G. H.,
“Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 75, no. 3, pp. 845-854, 2020.
L. Shinto, Lahna, D., Murchison, C. F., Dodge, H., Hagen, K., David, J., Kaye, J., Quinn, J. F., Wall, R., and Silbert, L. C.,
“Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated with Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults.”,
J Alzheimers Dis, vol. 74, no. 1, pp. 65-77, 2020.
A. R. Trammell, McDaniel, D. J., Obideen, M., Okafor, M., Thomas, T. L., Goldstein, F. C., Shaw, L. M., and Hajjar, I. M.,
“Perceived Stress is Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in African Americans with Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 77, no. 2, pp. 843-853, 2020.
U. S. Sandau, Wiedrick, J. T., Smith, S. J., McFarland, T. J., Lusardi, T. A., Lind, B., Harrington, C. A., Lapidus, J. A., Galasko, D. R., Quinn, J. F., and Saugstad, J. A.,
“Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 78, no. 1, pp. 245-263, 2020.
S. Pedrini, Hone, E., Gupta, V. B., James, I., Teimouri, E., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Rainey-Smith, S., Verdile, G., Sohrabi, H. R., Raida, M. R., Wenk, M. R., Taddei, K., Chatterjee, P., Martins, I., Laws, S. M., and Martins, R. N.,
“Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”,
J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
T. Soares Martins, Magalhães, S., Rosa, I. Martins, Vogelgsang, J., Wiltfang, J., Delgadillo, I., Catita, J., Silva, O. A. B. da Cru, Nunes, A., and Henriques, A. Gabriela,
“Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study.”,
J Alzheimers Dis, vol. 74, no. 1, pp. 391-405, 2020.
A. Heller, Coffman, S. S., and Jarvis, K.,
“Potentially Pathogenic Calcium Oxalate Dihydrate and Titanium Dioxide Crystals in the Alzheimer's Disease Entorhinal Cortex.”,
J Alzheimers Dis, vol. 77, no. 2, pp. 547-550, 2020.
Q. Cao, Tan, C. - C., Xu, W., Hu, H., Cao, X. - P., Dong, Q., Tan, L., and Yu, J. - T.,
“The Prevalence of Dementia: A Systematic Review and Meta-Analysis.”,
J Alzheimers Dis, vol. 73, no. 3, pp. 1157-1166, 2020.
K. Y. Liu, Costello, H., Reeves, S., and Howard, R.,
“The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 78, no. 3, pp. 1119-1127, 2020.
J. Li, Long, X., Huang, H., Tang, J., Zhu, C., Hu, S., Wu, J., Li, J., Lin, Z., and Xiong, N.,
“Resilience of Alzheimer's Disease to COVID-19.”,
J Alzheimers Dis, vol. 77, no. 1, pp. 67-73, 2020.
J. Li, Long, X., Huang, H., Tang, J., Zhu, C., Hu, S., Wu, J., Li, J., Lin, Z., and Xiong, N.,
“Resilience of Alzheimer's Disease to COVID-19.”,
J Alzheimers Dis, vol. 77, no. 1, pp. 67-73, 2020.
R. M. Wood, Garcia, Z., Daniels, N., Landon, S. M., Humayun, S., Lee, H. -gon, and Macpherson, L. J.,
“Selective Peripheral Taste Dysfunction in APP/PS1 Mutant Transgenic Mice.”,
J Alzheimers Dis, 2020.
P. Chatterjee, Mohammadi, M., Goozee, K., Shah, T. M., Sohrabi, H. R., Dias, C. B., Shen, K., Asih, P. R., Dave, P., Pedrini, S., Ashton, N. J., Hye, A., Taddei, K., Lovejoy, D. B., Zetterberg, H., Blennow, K., and Martins, R. N.,
“Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”,
J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
M. Defrancesco, Marksteiner, J., Kemmler, G., Dal-Bianco, P., Ransmayr, G., Benke, T., Mosbacher, J., Höller, Y., and Schmidt, R.,
“Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).”,
J Alzheimers Dis, vol. 73, no. 1, pp. 125-133, 2020.
C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S.,
“Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”,
J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S.,
“Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”,
J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
A. Kapoor, Bartha, R., Black, S. E., Borrie, M., Freedman, M., Gao, F., Herrmann, N., Mandzia, J., Ozzoude, M., Ramirez, J., Scott, C. J. M., Symons, S., Fischer, C. E., Frank, A., Seitz, D., Wolf, M. Uri, Verhoeff, N. Paul L. G., Naglie, G., Reichman, W., Masellis, M., Mitchell, S. B., Tang-Wai, D. F., Tartaglia, M. Carmela, Kumar, S., Pollock, B. G., Rajji, T. K., Finger, E., Pasternak, S. H., and Swartz, R. H.,
“Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”,
J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E.,
“Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”,
J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
F. Clay, Howett, D., Fitzgerald, J., Fletcher, P., Chan, D., and Price, A.,
“Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review.”,
J Alzheimers Dis, vol. 75, no. 1, pp. 23-43, 2020.
S. Gill, Mouches, P., Hu, S., Rajashekar, D., MacMaster, F. P., Smith, E. E., Forkert, N. D., and Ismail, Z.,
“Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data.”,
J Alzheimers Dis, vol. 75, no. 1, pp. 277-288, 2020.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S.,
“Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”,
J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
] 